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Abstract To investigate the in£uence of glutathione (GSH) on
cellular e¡ects of nitric oxide (NO) formation, human colon
adenocarcinoma cells were transfected with a vector allowing
controlled expression of inducible nitric oxide synthase
(iNOS). Protein levels of oxidative stress-sensitive heme oxy-
genase-1 (HO-1) were analyzed in the presence or absence of
GSH depletion using L-buthionine-[S,R]-sulfoximine and iNOS
induction. While no e¡ect was observed in the presence of iNOS
activity alone, a synergistic e¡ect on HO-1 expression was ob-
served in the presence of iNOS expression and GSH depletion.
This e¡ect was prevented by addition of N-methyl-L-arginine.
Therefore, targeting of endogenous NO may be modulated by
intracellular GSH.
, 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Nitric oxide (NO) is a signaling molecule involved in a wide
variety of biological processes [1]. The cellular redox environ-
ment plays an important role in NO e¡ects. Indeed, direct
e¡ects depend on reactions between NO radical and speci¢c
biological molecules, such as metal centers or other radicals,
while indirect e¡ects will result from reactions of reactive
nitrogen oxide species (RNOS), derived from NO auto-oxida-
tion, with various biological targets including thiols [2].
The intracellular environment is generally in a reducing
state because of glutathione (GSH), which is present in vir-
tually all cells in millimolar concentration [3]. GSH depletion
has often been used to simulate oxidative conditions [4,5].
In order to investigate modulations of NO e¡ects by the
redox environment, the expression of heme oxygenase-1 (HO-
1), the inducible form of heme oxygenase, was determined.
HO-1 is a microsomal membrane and a stress response pro-
tein that is induced by a variety of stimuli including heme, salt
of heavy metals, GSH depleters or NO donors. Most of the
known HO-1 inducers stimulate the production of reactive
oxygen species or lead to a low GSH level [6].
Instead of delivering NO using an exogenous donor, which
may not re£ect endogenous delivery, NO exposure was
achieved by transfection of inducible nitric oxide synthase
(iNOS) which produces a sustained amount of NO. To have
a controlled production of NO, the bacterial isopropyl-L-D-
thiogalactoside (IPTG)-regulated lac system was used [7].
2. Materials and methods
2.1. DLD-1 cells transfected with a vector allowing controlled
expression of iNOS
Human adenocarcinoma cells, DLD-1 (ATCC No. CCL-221),
grown as described previously [8], were transfected with the plasmid
placOP-iNOS. The latter allows IPTG-inducible expression of iNOS
and was constructed by insertion of murine iNOS cDNA (kind gift of
Dr. Lowenstein, The Johns Hopkins University School of Medicine,
Baltimore, MD, USA) into placIOP [9]. Several clones were isolated
by addition of hygromycin 200 Wg/ml (Roche Applied Biosciences,
Rotkreuz, Switzerland). Cells were plated at 36 000/cm2 and iNOS
expression was induced by addition of 60 WM IPTG (Eurogentec,
Seraing, Belgium) during 72 h. The clone with the highest inducible
expression was selected for investigation of HO-1 induction.
2.2. GSH depletion
To deplete the GSH level, cells were incubated for 48 h with 6 WM
L-buthionine-[S,R]-sulfoximine (BSO, Sigma, Buchs, Switzerland) [10].
Cellular GSH content was veri¢ed using the 5,5P-dithiobis-2-nitroben-
zoic acid reduction assay [11].
2.3. Western blot analysis
Preparation of cellular extracts, protein determination and Western
blot analysis were performed as previously described [8,12]. The
equivalent of 20 Wg of total protein was separated on 12% sodium
dodecyl sulfate^polyacrylamide gel electrophoresis. Polyclonal anti-
iNOS (Transduction Laboratories, Lexington, KY, USA), anti-actin
(Sigma), and anti-HO-1 (Stressgen Biotechnologies, Victoria, BC,
Canada) were diluted at 1:1000, 1:2000 and 1:4000, respectively. De-
tection was achieved by enhanced chemiluminescence (Amersham
Pharmacia, Dubendorf, Switzerland) and densitometry was performed
on non-saturated ¢lms.
2.4. iNOS activity
Activity of iNOS was assessed indirectly by measuring nitrite accu-
mulation in conditioned medium [12]. To inhibit NO production, N-
methyl-L-arginine (L-NMA, Alexis Biochemicals, Lausen, Switzer-
land) was used at 1 mM concentration [13].
2.5. Real-time polymerase chain reaction (PCR)
Total RNA was isolated as previously described [12] from 2U107
cells 48 h and 24 h after IPTG or BSO addition, respectively. Reverse
transcription (RT) was performed on 1 Wg using AMV reverse tran-
scriptase (Promega). The resulting cDNA was ampli¢ed by the SYBR-
Green PCR assay, and products were detected on a Prism 5700 de-
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tection system (SDS, ABI/Perkin Elmer). Histone RNA was used to
standardize the total amount of cDNA. Primers for HO-1 (CTGCG-
TTCCTGCTCAACATC and GGTCCTTGGTGTCATGGGTC) and
for histone (GGTAAAGCACCCAGGAAGCA and CCTCCAGTA-
GAGGGCGCAC) yielded PCR products of 69 and 64 bp, respec-
tively. Speci¢city of PCR was checked by analyzing the melting curve.
Relative mRNA levels were determined by comparing (a) PCR cycle
threshold between cDNA of HO-1 and histone (vC), and (b) vC
values between treated and untreated conditions (vvC).
2.6. Cell exposure to NO donor
In order to compare endogenous versus exogenous NO exposure,
parental DLD-1 cells were treated for 9 h with 20 or 200 WM of the
NO donor diethylenetriamine/NO (DETA/NO, kind gift of Dr. Larry
Keefer, NCI, Frederick, MD, USA) in the presence or absence of
GSH depletion. Exposure time to DETA/NO was selected from a
time course experiment (3^24 h).
2.7. Statistical analysis
Statistical comparisons were carried out using a two-way analysis of
variance or a Mann^Whitney multiple comparison test.
3. Results
3.1. GSH depletion does not a¡ect endogenous synthesis of NO
iNOS-transfected DLD-1 cells were plated in the presence
or absence of IPTG and treated with BSO to deplete GSH
content. iNOS protein could only be detected in the presence
of IPTG as shown by Western blot analysis (Fig. 1A). The
capacity of this newly synthesized iNOS to produce NO was
assessed by nitrite (NO32 ) accumulation in conditioned me-
dium, which was used as a re£ection of NO production. After
72 h in the presence of IPTG, a signi¢cant 11-fold increase in
nitrite accumulation was observed (F ratio = 21.5; df = 1,24;
P6 0.005; Fig. 1B). No di¡erences in iNOS expression (Fig.
1A) or nitrite measurement (Fig. 1B) were observed with
BSO.
The total amount of GSH was 52.7P 8.3 pmol GSH/Wg of
proteins (n=3) in iNOS-transfected DLD-1 cells (Fig. 2). As-
suming that proteins correspond to 16% of cellular content,
the intracellular GSH level was estimated approximately to be
5 mM, consistent with values available in the literature [3].
This concentration was not signi¢cantly di¡erent in parental
DLD-1 cells (data not shown). Incubation for 48 h with 6 WM
BSO resulted in a signi¢cant 89% decrease of GSH content (F
ratio = 178.9; df = 1,8; P6 0.005; Fig. 2). IPTG alone had no
e¡ect on GSH level nor did it modify the BSO e¡ect on this
parameter (Fig. 2).
3.2. Modulation of HO-1 expression by NO production and
GSH depletion
HO-1 expression in iNOS-transfected DLD-1 cells was de-
termined by Western blot analysis (Fig. 3A). Cellular extracts
from DLD-1 cells exposed to cadmium chloride (50 WM, 6 h)
were used as positive control [14]. Normalized HO-1 expres-
sion showed a signi¢cant induction of 2.0 P 0.3-fold (n=9)
with BSO (F ratio = 60.5; df = 1,32; P6 0.005; Fig. 3A,B).
NO produced in the presence of IPTG had no inducing e¡ect
per se (Fig. 3A,B). However, IPTG had a synergistic e¡ect on
BSO-dependent induction of HO-1 expression (3.1 P 0.4-fold
Fig. 1. Characterization of DLD-1 cells transfected with a vector al-
lowing controlled expression of iNOS. A: Western blot analysis of
cellular extracts from iNOS-transfected DLD-1 cells cultured in the
presence or absence of IPTG (60 WM, 72 h) and/or BSO (6 WM, 48
h). B: Nitrite accumulation in the conditioned medium. MeanP
S.E.M., n=7.
Fig. 2. Measurement of GSH depletion in iNOS-transfected DLD-1
cells exposed to 6 WM BSO added 24 h after IPTG (60 WM, 72 h).
MeanPS.D., n=3.
Table 1
Real-time PCR of HO-1 expression
vC Fold induction
Control 6.90P 0.38
BSO 6.79P 0.11 1.1P 0.1
IPTG 7.30P 0.27 0.8P 0.1
IPTG+BSO 6.32P 0.08 1.5P 0.1
Relative mRNA levels were determined by comparing the PCR
cycle threshold between cDNA of HO-1 and histone (vC), and the
fold induction was calculated by 2vvC , where vvC is the di¡erence
between untreated and treated conditions. MeanPS.D., n=3.
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induction in IPTG+BSO condition, n=9; F ratio = 9.0;
df = 1,32; P6 0.01; Fig. 3A,B).
This synergism between IPTG and BSO treatments was
buttressed by real-time RT-PCR of HO-1 expression (F ra-
tio = 9.8; df = 1,8; P6 0.05; Table 1).
To verify that the IPTG e¡ect was due to NO production,
L-NMA, an inhibitor of iNOS, was employed. Addition of
1 mM L-NMA to iNOS-transfected DLD-1 cells in the pres-
ence of IPTG led to 86% inhibition of nitrite accumulation in
the conditioned medium (P6 0.01, Mann^Whitney test ; Fig.
4A). The same range of decrease in nitrite measurement due
to L-NMA was observed in the presence of IPTG and BSO
treatments (Fig. 4A). L-NMA had no e¡ect on HO-1 expres-
sion in the presence of IPTG alone as shown by Western blot
analysis (Fig. 4B,C). On the other hand, L-NMA signi¢cantly
decreased HO-1 expression from 3.9 P 0.7-fold induction
(n=18) to 2.1P 0.4-fold (n=8) in the presence of IPTG and
BSO treatments (P6 0.05, Mann^Whitney test ; Fig. 4B,C).
The speci¢city of NO implication was further con¢rmed by
the absence of an IPTG e¡ect on BSO-induced HO-1 expres-
sion in DLD-1 parental cells (data not shown).
3.3. Exposure to NO donor
In order to compare the e¡ect of endogenous production of
NO in iNOS-transfected DLD-1 cells with exposure to exog-
enous NO, parental DLD-1 cells were treated with the NO
donor DETA/NO. An accumulation of nitrite in the condi-
tioned medium was observed only in DLD-1 cells exposed to
DETA/NO (Fig. 5A). Normalized HO-1 expression deter-
mined by Western blot analysis (Fig. 5B) showed a signi¢cant
induction of 2.8 P 0.2-fold (n=11) with BSO (F ratio = 19.5;
df = 1,28; P6 0.01; Fig. 5C). Only the highest DETA/NO
concentration used (200 WM) had an inducible e¡ect on
HO-1 (F ratio = 7.8; df = 1,28; P6 0.01; Fig. 5C), and an
Fig. 3. Synergistic e¡ect of GSH depletion and iNOS expression on
HO-1 induction. A: Investigation of HO-1 expression by Western
blot analysis of cellular extracts from iNOS-transfected DLD-1 cells
cultured in the presence or absence of IPTG (60 WM, 72 h) and/or
BSO (6 WM, 48 h). Cellular extracts from cadmium chloride (50
WM, 6 h)-exposed DLD-1 cells were used as positive control. B:
Quanti¢cation normalized by actin. MeanPS.E.M., n=9.
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Fig. 4. E¡ect of iNOS inhibitor. A: Nitrite accumulation in condi-
tioned medium of iNOS-transfected cells cultured in the presence or
absence of IPTG (60 WM, 72 h), BSO (6 WM, 48 h) and L-NMA
(1 mM, 72 h). MeanPS.E.M., n=8. B: Western blot analysis of
HO-1 expression in cellular extracts. C: Quanti¢cation of Western
blot analysis normalized by actin. MeanPS.E.M., n=8^18.
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additive e¡ect with BSO. DETA/NO 20 WM had no e¡ect per
se and did not modify BSO-driven induction (Fig. 5C).
4. Discussion
Investigation of HO-1 expression has often been used as the
endpoint to document cellular response to changes in redox
homeostasis [15,16]. The synergistic e¡ect of GSH depletion
and oxidative stress on HO-1 induction and the reversibility of
these e¡ects by N-acetyl-cysteine have also been documented
[17], whereas the in£uence of the redox environment on NO
produced endogenously is less well characterized. In addition,
most investigations on HO-1 induction by NO have been
performed with NO donors [14,18,19], which may not re£ect
actual regulation of HO-1 expression by NO in vivo. Indeed,
experimental evidence suggests modulation of NO-dependent
HO-1 induction by the in vivo environment. In fact, when
HO-1 expression was observed in endothelial cells exposed
to reduced oxygen tension for 18 h, it was associated with
increased levels of nitrosothiols and iNOS expression. How-
ever, only N-acetyl-cysteine but not iNOS inhibitors were able
to completely prevent the hypoxia e¡ect [20]. Similarly, in rat
hepatocytes stimulated with cytokines and endotoxins, in-
creased HO-1 activity was not completely prevented by
NOS inhibitors [21].
In order to determine the individual contribution of endog-
enous NO independently of other cellular modi¢cations, a
simple system was therefore set up. DLD-1 cells were trans-
fected with a vector allowing controlled expression of iNOS.
A signi¢cant induction of HO-1 was observed with BSO,
which depleted cellular GSH even in the absence of iNOS
activity. This result is consistent with previous observations,
where BSO was either added to ¢broblasts in culture or ad-
ministered intraperitoneally to rats [10,22]. In the presence of
IPTG alone, iNOS was induced, but no e¡ect on HO-1 ex-
pression was detected. This result does not seem to be related
to cell type since the same observations were obtained with
the ecdysone-inducible expression system transfected in hu-
man fetal kidney cells developed by Xu et al. [23] (data not
shown). On the other hand, a synergistic e¡ect on HO-1 ex-
pression was shown in the presence of IPTG and GSH deple-
tion. Moreover, addition of L-NMA decreased nitrite accu-
mulation in conditioned medium and was able to prevent this
IPTG-dependent e¡ect, demonstrating the involvement of NO
production. Therefore, modulation of cellular GSH content
was able to modify targeting of endogenous NO. This is con-
sistent with the observation that NO contributes to HO-1
induction under hypoxia, where a decrease in GSH level
was also observed [20].
Possible mechanisms of NO-dependent potentiation of
GSH depletion can be inferred from recent knowledge on
regulation of HO-1 expression. At the transcriptional level,
HO-1 is regulated mainly by alleviation of repression medi-
ated by the hemoprotein Bach1 [24]. Upon increase of the
heme level, Bach1 is released and allows activators such as
Nrf2 to bind enhancer regions [25]. A transcription-indepen-
dent increase of HO-1 expression, due to stabilization of
mRNA, has also been described [18]. As mentioned above,
HO-1 induction has been demonstrated using NO donors
and both transcription-dependent and -independent e¡ects
have been attributed to RNOS, in particular nitrosothiols
[14,18,20]. In our system, endogenously produced NO is not
e⁄ciently metabolized to species able to induce HO-1,
although the levels of NO production achieved are compara-
ble to those obtained by cytokine-stimulated human cells or
other recombinant systems [23,26,27]. These results are con-
sistent with the observation that the NO donor DETA/NO 20
WM, which releases NO levels similar to endogenous produc-
tion, was not able to induce HO-1. On the other hand, ex-
posure to 200 WM DETA/NO led to HO-1 induction as de-
scribed in other studies [18,19]. However, exogenous donor
was not able to elicit potentiation of the BSO e¡ect at these
concentrations, highlighting the importance of intracellular
NO delivery.
To explain the synergistic induction observed with iNOS
expression and GSH depletion, di¡erent scenarios can be con-
sidered. One possibility is that low GSH content increases
formation of nitrosothiols. However, no detectable increase
in intracellular 4,5-diamino£uorescein-2 £uorescence, which
is sensitive to nitrosating agents [28], was observed (Espey,
Fig. 5. E¡ect of exposure to NO donor. A: Nitrite accumulation in
conditioned medium of DLD-1 cells treated with DETA/NO 20 or
200 WM, 9 h and/or BSO (6 WM, 48 h). MeanPS.E.M., n=3^8. B:
Western blot analysis of HO-1 expression in cellular extracts. C:
Quanti¢cation of Western blot analysis normalized by actin.
MeanPS.E.M., n=3^11.
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personal communication). In addition, di¡erent redox modi-
¢cations of cysteine residues have been recently suggested to
mediate a graduated response, but changes due to RNOS were
less e¡ective compared to other stresses [29], rendering this
hypothesis di⁄cult to reconcile with a synergistic e¡ect. Alter-
natively, NO would potentiate the GSH depletion e¡ect by
acting via a nitrosation-independent mechanism. Indeed, HO-
1 is negatively regulated by Bach1 in most tissues including
intestine [24]. Therefore it is possible that NO disrupts this
negative regulation by interaction with the heme prosthetic
group of Bach1, thereby leading to a potentiation of GSH
depletion. Interestingly, another recent study shows that while
NO has no e¡ect per se, it potentiates Angeli’s salt-dependent
HO-1 induction [19]. Finally, it is possible that stabilization of
HO-1 mRNA, previously observed using NO donors [18], is
achieved by endogenous NO only in the presence of a low
GSH level.
In conclusion, this study showed that endogenous NO per
se is not su⁄cient to induce HO-1, but potentiates the e¡ects
of GSH depletion. Although the mechanisms involved have
not been identi¢ed yet, the set-up of a controlled model of
endogenous NO production will make it possible to address
these questions.
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